PerkinElmer Announces Financial Results for the Third Quarter of 2021
- Revenue of $1.17 billion; 21% reported growth; 12% organic growth
- GAAP EPS from continuing operations of $1.11; Adjusted EPS of $2.31
- Initiates Fourth Quarter Guidance and Raises Full Year Revenue and Earnings Guidance
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 3, 2021.
The Company reported GAAP earnings per share from continuing operations of $1.11, as compared to GAAP earnings per share from continuing operations of $1.57 in the third quarter of 2020. GAAP revenue for the quarter was $1.17 billion, as compared to $964 million in the third quarter of 2020. GAAP operating income from continuing operations for the quarter was $222 million, as compared to $248 million for the same period a year ago. GAAP operating profit margin was 19.0% as a percentage of revenue, as compared to 25.7% in the third quarter of 2020.
Adjusted earnings per share from continuing operations for the quarter was $2.31, as compared to $2.09 in the third quarter of 2020. Adjusted revenue for the quarter was $1.17 billion, as compared to $964 million in the third quarter of 2020. Adjusted operating income from continuing operations for the quarter was $359 million, as compared to $304 million for the same period a year ago. Adjusted operating profit margin was 30.8% as a percentage of adjusted revenue, as compared to 31.6% in the third quarter of 2020.
Adjustments for the Company’s non-GAAP financial measures have been noted in the attached reconciliations.
“I am proud of the team’s tireless efforts to proactively respond to and execute for our customers around the world, driving double digit core growth in all major regions during the third quarter,” said Prahlad Singh, president and chief executive officer of PerkinElmer. “Just as importantly, we are embracing new opportunities as we welcome the latest additions to the PerkinElmer family and develop innovative solutions to push the boundaries of what’s possible.”
Financial Overview by Reporting Segment for the Third Quarter
Discovery & Analytical Solutions
- Third quarter 2021 revenue was $513 million, as compared to $424 million for the third quarter of 2020. Reported revenue increased 21% and organic revenue increased 10% as compared to the third quarter of 2020.
- Third quarter 2021 operating income from continuing operations was $7 million, as compared to $43 million for the third quarter of 2020.
- Third quarter 2021 adjusted operating income was $95 million, as compared to $62 million for the third quarter of 2020.
Diagnostics
- Third quarter 2021 revenue was $654 million, as compared to $540 million for the third quarter of 2020. Reported revenue increased 21% and organic revenue increased 13% as compared to the third quarter of 2020.
- Third quarter 2021 operating income from continuing operations was $238 million, as compared to $224 million for the third quarter of 2020.
- Third quarter 2021 adjusted operating income was $287 million, as compared to $260 million for the third quarter of 2020.
Initiates Fourth Quarter Guidance and Raises Full Year 2021 Guidance
For the fourth quarter of 2021, the Company forecasts adjusted revenue of approximately $1.2 billion and adjusted earnings per share of $2.05.
For the full year 2021, the Company now forecasts adjusted revenue of $4.9 billion and adjusted earnings per share of $10.81.
Guidance for the fourth quarter and full year is provided on a non-GAAP basis and cannot be reconciled to the closest GAAP measures without unreasonable effort due to the unpredictability of the amounts and timing of events affecting the items the Company excludes from these non-GAAP measures. The timing and amounts of such events and items could be material to the Company’s results prepared in accordance with GAAP.
Conference Call and Webcast Information
The Company will discuss its third quarter 2021 results and its outlook for business trends during a conference call on November 2, 2021 at 5:00 p.m. Eastern Time. A live audio webcast of the call will be available on the Investors section of the Company’s website, www.perkinelmer.com.
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.
Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “estimates”, “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) the effect of the COVID-19 pandemic on our sales and operations; (3) fluctuations in the global economic and political environments; (4) our failure to introduce new products in a timely manner; (5) our ability to execute acquisitions, such as BioLegend, and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (6) our ability to compete effectively; (7) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (8) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (9) disruptions in the supply of raw materials and supplies; (10) our ability to retain key personnel; (11) significant disruption in our information technology systems, or cybercrime; (12) our ability to realize the full value of our intangible assets; (13) our failure to adequately protect our intellectual property; (14) the loss of any of our licenses or licensed rights; (15) the manufacture and sale of products exposing us to product liability claims; (16) our failure to maintain compliance with applicable government regulations; (17) regulatory changes; (18) our failure to comply with healthcare industry regulations; (19) economic, political and other risks associated with foreign operations; (20) the United Kingdom’s withdrawal from the European Union; (21) our ability to obtain future financing; (22) restrictions in our credit agreements; (23) discontinuation or replacement of LIBOR; (24) significant fluctuations in our stock price; (25) reduction or elimination of dividends on our common stock; and (26) other factors which we describe under the caption “Risk Factors” in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $3.8 billion in 2020, has about 15,000 employees serving customers in more than 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.
|
PerkinElmer, Inc. and Subsidiaries |
|||||||||||||||||
|
CONDENSED CONSOLIDATED INCOME STATEMENTS |
|||||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
|||||||||||||||
| (In thousands, except per share data) |
October 3, 2021 |
|
October 4, 2020 |
|
October 3, 2021 |
|
October 4, 2020 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| Revenue |
$ |
1,166,684 |
|
|
$ |
964,025 |
|
|
$ |
3,702,844 |
|
|
$ |
2,428,139 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Cost of revenue |
|
534,848 |
|
|
|
436,580 |
|
|
|
1,600,668 |
|
|
|
1,145,327 |
|
||
| Selling, general and administrative expenses |
|
339,047 |
|
|
|
225,249 |
|
|
|
872,276 |
|
|
|
654,844 |
|
||
| Research and development expenses |
|
68,608 |
|
|
|
50,131 |
|
|
|
194,648 |
|
|
|
148,566 |
|
||
| Restructuring and other costs, net |
|
2,211 |
|
|
|
4,059 |
|
|
|
13,018 |
|
|
|
11,075 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Operating income from continuing operations |
|
221,970 |
|
|
|
248,006 |
|
|
|
1,022,234 |
|
|
|
468,327 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Interest income |
|
(544 |
) |
|
|
(205 |
) |
|
|
(1,322 |
) |
|
|
(662 |
) |
||
| Interest expense |
|
43,531 |
|
|
|
12,057 |
|
|
|
74,407 |
|
|
|
37,308 |
|
||
| Change in fair value of financial securities |
|
19,365 |
|
|
|
(35 |
) |
|
|
(8,566 |
) |
|
|
(35 |
) |
||
| Other (income) expense, net |
|
(2,050 |
) |
|
|
2,432 |
|
|
|
(10,492 |
) |
|
|
(1,557 |
) |
||
|
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations, before income taxes |
|
161,668 |
|
|
|
233,757 |
|
|
|
968,207 |
|
|
|
433,273 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Provision for income taxes |
|
33,883 |
|
|
|
57,021 |
|
|
|
215,111 |
|
|
|
85,609 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Income from continuing operations |
|
127,785 |
|
|
|
176,736 |
|
|
|
753,096 |
|
|
|
347,664 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Loss on disposition of discontinued operations, before income taxes |
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
||
| Provision for income taxes on discontinued operations and dispositions |
|
47 |
|
|
|
37 |
|
|
|
123 |
|
|
|
138 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Loss from discontinued operations and dispositions |
|
(47 |
) |
|
|
(37 |
) |
|
|
(123 |
) |
|
|
(138 |
) |
||
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ |
127,738 |
|
|
$ |
176,699 |
|
|
$ |
752,973 |
|
|
$ |
347,526 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| Diluted earnings per share: |
|
|
|
|
|
|
|
||||||||||
| Income from continuing operations |
$ |
1.11 |
|
|
$ |
1.57 |
|
|
$ |
6.65 |
|
|
$ |
3.11 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Loss from discontinued operations and dispositions |
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
||
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ |
1.11 |
|
|
$ |
1.57 |
|
|
$ |
6.65 |
|
|
$ |
3.10 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| Weighted average diluted shares of common stock outstanding |
|
115,022 |
|
|
|
112,292 |
|
|
|
113,307 |
|
|
|
111,935 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
|
ABOVE PREPARED IN ACCORDANCE WITH GAAP |
|||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| Additional Supplemental Information (1): |
|
|
|
|
|
|
|
||||||||||
| (per share, continuing operations) |
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| GAAP EPS from continuing operations |
$ |
1.11 |
|
|
$ |
1.57 |
|
|
$ |
6.65 |
|
|
$ |
3.11 |
|
||
| Amortization of intangible assets |
|
0.62 |
|
|
|
0.44 |
|
|
|
1.63 |
|
|
|
1.28 |
|
||
| Purchase accounting adjustments |
|
0.09 |
|
|
|
0.03 |
|
|
|
0.17 |
|
|
|
(0.06 |
) |
||
| Acquisition and divestiture-related costs |
|
0.63 |
|
|
|
0.00 |
|
|
|
0.77 |
|
|
|
0.07 |
|
||
| Change in fair value of financial securities |
|
0.17 |
|
|
|
(0.00 |
) |
|
|
(0.08 |
) |
|
|
(0.00 |
) |
||
| Asset impairment |
|
0.03 |
|
|
|
– |
|
|
|
0.03 |
|
|
|
– |
|
||
| Significant litigation matters and settlements |
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
0.03 |
|
||
| Significant environmental matters |
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
0.05 |
|
||
| Disposition of businesses and assets, net |
|
(0.02 |
) |
|
|
– |
|
|
|
(0.02 |
) |
|
|
– |
|
||
| Restructuring and other, net |
|
0.02 |
|
|
|
0.04 |
|
|
|
0.11 |
|
|
|
0.10 |
|
||
| Tax on above items |
|
(0.34 |
) |
|
|
(0.12 |
) |
|
|
(0.55 |
) |
|
|
(0.37 |
) |
||
| Significant tax items |
|
(0.01 |
) |
|
|
0.14 |
|
|
|
0.12 |
|
|
|
0.14 |
|
||
| Adjusted EPS |
$ |
2.31 |
|
|
$ |
2.09 |
|
|
$ |
8.84 |
|
|
$ |
4.33 |
|
||
| (1) amounts may not sum due to rounding | |||||||||||||||||
| PerkinElmer, Inc. and Subsidiaries | |||||||||||||||||||
| REVENUE AND OPERATING INCOME (LOSS) | |||||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||
| (In thousands, except percentages) | October 3, 2021 | October 4, 2020 | October 3, 2021 | October 4, 2020 | |||||||||||||||
| DAS | Reported revenue |
$ |
512,879 |
|
$ |
423,623 |
|
$ |
1,480,317 |
|
$ |
1,213,020 |
|
||||||
| Purchase accounting adjustments |
– |
|
– |
|
1,849 |
|
– |
|
|||||||||||
| Adjusted revenue |
512,879 |
|
423,623 |
|
1,482,166 |
|
1,213,020 |
|
|||||||||||
| Reported operating income from continued operations |
7,146 |
|
42,689 |
|
114,248 |
|
110,632 |
|
|||||||||||
| OP% |
1.4 |
% |
10.1 |
% |
7.7 |
% |
9.1 |
% |
|||||||||||
| Amortization of intangible assets |
33,437 |
|
17,607 |
|
76,929 |
|
58,823 |
|
|||||||||||
| Purchase accounting adjustments |
5,673 |
|
– |
|
9,322 |
|
(11,334 |
) |
|||||||||||
| Acquisition and divestiture-related costs |
47,059 |
|
212 |
|
61,564 |
|
7,045 |
|
|||||||||||
| Significant litigation matters and settlements |
– |
|
– |
|
– |
|
2,399 |
|
|||||||||||
| Restructuring and other, net |
1,624 |
|
1,979 |
|
9,368 |
|
6,733 |
|
|||||||||||
| Adjusted operating income |
94,939 |
|
62,487 |
|
271,431 |
|
174,298 |
|
|||||||||||
| Adjusted OP% |
18.5 |
% |
14.8 |
% |
18.3 |
% |
14.4 |
% |
|||||||||||
| Diagnostics | Reported revenue |
653,805 |
|
540,402 |
|
2,222,527 |
|
1,215,119 |
|
||||||||||
| Purchase accounting adjustments |
199 |
|
196 |
|
597 |
|
588 |
|
|||||||||||
| Adjusted revenue |
654,004 |
|
540,598 |
|
2,223,124 |
|
1,215,707 |
|
|||||||||||
| Reported operating income from continued operations |
237,903 |
|
223,819 |
|
965,650 |
|
413,710 |
|
|||||||||||
| OP% |
36.4 |
% |
41.4 |
% |
43.4 |
% |
34.0 |
% |
|||||||||||
| Amortization of intangible assets |
37,517 |
|
31,292 |
|
107,743 |
|
84,043 |
|
|||||||||||
| Purchase accounting adjustments |
5,107 |
|
3,107 |
|
9,485 |
|
4,872 |
|
|||||||||||
| Asset impairment |
3,868 |
|
– |
|
3,868 |
|
– |
|
|||||||||||
| Acquisition and divestiture-related costs |
2,023 |
|
18 |
|
7,833 |
|
323 |
|
|||||||||||
| Significant litigation matters and settlements |
– |
|
– |
|
– |
|
1,245 |
|
|||||||||||
| Restructuring and other, net |
587 |
|
2,080 |
|
3,650 |
|
4,342 |
|
|||||||||||
| Adjusted operating income |
287,005 |
|
260,316 |
|
1,098,229 |
|
508,535 |
|
|||||||||||
| Adjusted OP% |
43.9 |
% |
48.2 |
% |
49.4 |
% |
41.8 |
% |
|||||||||||
| Corporate | Reported operating loss |
(23,079 |
) |
(18,502 |
) |
(57,664 |
) |
(56,015 |
) |
||||||||||
| Significant environmental matters |
– |
|
– |
|
– |
|
5,242 |
|
|||||||||||
| Adjusted operating loss |
(23,079 |
) |
(18,502 |
) |
(57,664 |
) |
(50,773 |
) |
|||||||||||
| Continuing Operations | Reported revenue |
$ |
1,166,684 |
|
$ |
964,025 |
|
$ |
3,702,844 |
|
$ |
2,428,139 |
|
||||||
| Purchase accounting adjustments |
199 |
|
196 |
|
2,446 |
|
588 |
|
|||||||||||
| Adjusted revenue |
1,166,883 |
|
964,221 |
|
3,705,290 |
|
2,428,727 |
|
|||||||||||
| Reported operating income from continued operations |
221,970 |
|
248,006 |
|
1,022,234 |
|
468,327 |
|
|||||||||||
| OP% |
19.0 |
% |
25.7 |
% |
27.6 |
% |
19.3 |
% |
|||||||||||
| Amortization of intangible assets |
70,954 |
|
48,899 |
|
184,672 |
|
142,866 |
|
|||||||||||
| Purchase accounting adjustments |
10,780 |
|
3,107 |
|
18,807 |
|
(6,462 |
) |
|||||||||||
| Acquisition and divestiture-related costs |
49,082 |
|
230 |
|
69,397 |
|
7,368 |
|
|||||||||||
| Asset impairment |
3,868 |
|
– |
|
3,868 |
|
– |
|
|||||||||||
| Significant litigation matters and settlements |
– |
|
– |
|
– |
|
3,644 |
|
|||||||||||
| Significant environmental matters |
– |
|
– |
|
– |
|
5,242 |
|
|||||||||||
| Restructuring and other, net |
2,211 |
|
4,059 |
|
13,018 |
|
11,075 |
|
|||||||||||
| Adjusted operating income |
$ |
358,865 |
|
$ |
304,301 |
|
$ |
1,311,996 |
|
$ |
632,060 |
|
|||||||
| Adjusted OP% |
30.8 |
% |
31.6 |
% |
35.4 |
% |
26.0 |
% |
|||||||||||
| REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP | |||||||||||||||||||
| PerkinElmer, Inc. and Subsidiaries | ||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
|
(In thousands) |
October 3, 2021 | January 3, 2021 | ||||||
|
|
||||||||
|
Current assets: |
||||||||
|
Cash and cash equivalents |
$ |
487,373 |
$ |
402,036 |
||||
|
Accounts receivable, net |
|
947,805 |
|
1,155,109 |
||||
|
Inventories |
|
645,419 |
|
514,567 |
||||
|
Other current assets |
|
170,207 |
|
167,208 |
||||
|
Total current assets |
|
2,250,804 |
|
2,238,920 |
||||
|
|
||||||||
|
Property, plant and equipment, net |
|
537,710 |
|
368,304 |
||||
|
Operating lease right-of-use assets |
|
208,661 |
|
207,236 |
||||
|
Intangible assets, net |
|
4,160,736 |
|
1,365,693 |
||||
|
Goodwill |
|
7,420,271 |
|
3,447,114 |
||||
|
Other assets, net |
|
321,667 |
|
333,048 |
||||
|
Total assets |
$ |
14,899,849 |
$ |
7,960,315 |
||||
|
|
||||||||
|
Current liabilities: |
||||||||
|
Current portion of long-term debt |
$ |
4,485 |
$ |
380,948 |
||||
|
Accounts payable |
|
320,435 |
|
327,325 |
||||
|
Accrued expenses and other current liabilities |
|
820,109 |
|
943,916 |
||||
|
Total current liabilities |
|
1,145,029 |
|
1,652,189 |
||||
|
|
||||||||
|
Long-term debt |
|
5,099,077 |
|
1,609,701 |
||||
|
Long-term liabilities |
|
1,512,153 |
|
774,531 |
||||
|
Operating lease liabilities |
|
185,005 |
|
188,402 |
||||
|
Total liabilities |
|
7,941,264 |
|
4,224,823 |
||||
|
|
||||||||
|
Total stockholders’ equity |
|
6,958,585 |
|
3,735,492 |
||||
|
Total liabilities and stockholders’ equity |
$ |
14,899,849 |
$ |
7,960,315 |
||||
| PREPARED IN ACCORDANCE WITH GAAP | ||||||||
| PerkinElmer, Inc. and Subsidiaries | |||||||||||||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
|||||||||||||||
|
October 3, 2021 |
October 4, 2020 |
|
October 3, 2021 |
October 4, 2020 |
|||||||||||||
|
(In thousands) |
|
(In thousands) |
|||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| Operating activities: |
|
|
|
|
|
|
|
||||||||||
| Net income |
$ |
127,738 |
|
|
$ |
176,699 |
|
|
$ |
752,973 |
|
|
$ |
347,526 |
|
||
| Loss from discontinued operations and dispositions, net of income taxes |
|
47 |
|
|
|
37 |
|
|
|
123 |
|
|
|
138 |
|
||
| Income from continuing operations |
|
127,785 |
|
|
|
176,736 |
|
|
|
753,096 |
|
|
|
347,664 |
|
||
| Adjustments to reconcile income from continuing operations |
|
|
|
|
|
|
|
||||||||||
| to net cash provided by continuing operations: |
|
|
|
|
|
|
|
||||||||||
| Stock-based compensation |
|
6,597 |
|
|
|
7,117 |
|
|
|
18,957 |
|
|
|
19,770 |
|
||
| Restructuring and other, net |
|
2,211 |
|
|
|
4,059 |
|
|
|
13,018 |
|
|
|
11,075 |
|
||
| Depreciation and amortization |
|
87,113 |
|
|
|
62,474 |
|
|
|
232,935 |
|
|
|
182,521 |
|
||
| Change in fair value of contingent consideration |
|
1,076 |
|
|
|
2,639 |
|
|
|
1,553 |
|
|
|
(8,807 |
) |
||
| Amortization of deferred debt financing costs and accretion of discounts |
|
1,500 |
|
|
|
917 |
|
|
|
3,224 |
|
|
|
2,559 |
|
||
| Change in fair value of financial securities |
|
19,365 |
|
|
|
– |
|
|
|
(8,566 |
) |
|
|
– |
|
||
| Amortization of acquired inventory revaluation |
|
9,425 |
|
|
|
272 |
|
|
|
14,728 |
|
|
|
1,757 |
|
||
| Loss on disposition of businesses and assets, net |
|
(1,970 |
) |
|
|
401 |
|
|
|
(1,970 |
) |
|
|
886 |
|
||
| Asset impairment |
|
3,868 |
|
|
|
– |
|
|
|
3,868 |
|
|
|
– |
|
||
| Changes in assets and liabilities which provided (used) cash, excluding |
|
|
|
|
|
|
|
|
|
||||||||
| effects from companies acquired: |
|
|
|
|
|
|
|
|
|||||||||
| Accounts receivable, net |
|
87,115 |
|
|
|
(72,007 |
) |
|
|
242,386 |
|
|
|
(67,695 |
) |
||
| Inventories |
|
(923 |
) |
|
|
5,773 |
|
|
|
6,316 |
|
|
|
(120,934 |
) |
||
| Accounts payable |
|
(10,206 |
) |
|
|
(4,517 |
) |
|
|
(37,002 |
) |
|
|
16,391 |
|
||
| Accrued expenses and other |
|
(19,161 |
) |
|
|
27,569 |
|
|
|
(167,385 |
) |
|
|
24,893 |
|
||
| Net cash provided by operating activities of continuing operations |
|
313,795 |
|
|
|
211,433 |
|
|
|
1,075,158 |
|
|
|
410,080 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Investing activities: |
|
|
|
|
|
|
|
||||||||||
| Capital expenditures |
|
(32,784 |
) |
|
|
(20,253 |
) |
|
|
(67,459 |
) |
|
|
(57,391 |
) |
||
| Purchases of investments |
|
(4,623 |
) |
|
|
(2,166 |
) |
|
|
(19,130 |
) |
|
|
(9,559 |
) |
||
| Proceeds from surrender of life insurance policies |
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
131 |
|
||
| Proceeds from disposition of businesses and assets |
|
1,460 |
|
|
|
608 |
|
|
|
1,460 |
|
|
|
2,423 |
|
||
| Cash paid for acquisitions, net of cash, cash equivalents and restricted cash acquired |
|
(3,264,981 |
) |
|
|
(712 |
) |
|
|
(3,967,678 |
) |
|
|
(3,702 |
) |
||
| Net cash used in investing activities of continuing operations |
|
(3,300,928 |
) |
|
|
(22,523 |
) |
|
|
(4,052,807 |
) |
|
|
(68,098 |
) |
||
|
|
|
|
|
|
|
|
|||||||||||
| Financing Activities: |
|
|
|
|
|
|
|
||||||||||
| Payments on borrowings |
|
(427,580 |
) |
|
|
(225,210 |
) |
|
|
(1,191,125 |
) |
|
|
(515,210 |
) |
||
| Proceeds from borrowings |
|
415,282 |
|
|
|
69,000 |
|
|
|
1,144,282 |
|
|
|
257,000 |
|
||
| Proceeds from term loan |
|
500,000 |
|
|
|
– |
|
|
|
500,000 |
|
|
|
– |
|
||
| Payments of senior debt |
|
– |
|
|
|
– |
|
|
|
(339,605 |
) |
|
|
– |
|
||
| Proceeds from sale of senior debt |
|
2,286,239 |
|
|
|
– |
|
|
|
3,086,095 |
|
|
|
– |
|
||
| Payments of debt financing costs |
|
(22,741 |
) |
|
|
– |
|
|
|
(30,983 |
) |
|
|
– |
|
||
| Settlement of cash flow hedges |
|
4,477 |
|
|
|
(7,126 |
) |
|
|
(1,459 |
) |
|
|
(2,089 |
) |
||
| Net payments on other credit facilities |
|
(905 |
) |
|
|
(2,088 |
) |
|
|
(12,731 |
) |
|
|
(8,124 |
) |
||
| Payments for acquisition-related contingent consideration |
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(5,200 |
) |
||
| Proceeds from issuance of common stock under stock plans |
|
8,575 |
|
|
|
17,454 |
|
|
|
22,760 |
|
|
|
27,528 |
|
||
| Purchases of common stock |
|
(89 |
) |
|
|
(159 |
) |
|
|
(73,013 |
) |
|
|
(6,829 |
) |
||
| Dividends paid |
|
(7,842 |
) |
|
|
(7,809 |
) |
|
|
(23,539 |
) |
|
|
(23,381 |
) |
||
| Net cash provided by (used in) financing activities of continuing operations |
|
2,755,416 |
|
|
|
(155,938 |
) |
|
|
3,080,682 |
|
|
|
(276,305 |
) |
||
|
|
|
|
|
|
|
|
|||||||||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
|
(5,925 |
) |
|
|
5,490 |
|
|
|
(16,584 |
) |
|
|
832 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash |
|
(237,642 |
) |
|
|
38,462 |
|
|
|
86,449 |
|
|
|
66,509 |
|
||
| Cash, cash equivalents, and restricted cash at beginning of period |
|
726,704 |
|
|
|
219,941 |
|
|
|
402,613 |
|
|
|
191,894 |
|
||
| Cash, cash equivalents, and restricted cash at end of period |
$ |
489,062 |
|
|
$ |
258,403 |
|
|
$ |
489,062 |
|
|
$ |
258,403 |
|
||
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
| Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
||||||||||
|
Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows: |
|
|
|
|
|
|
|
||||||||||
| Cash and cash equivalents |
$ |
487,373 |
|
|
$ |
258,293 |
|
|
$ |
487,373 |
|
|
$ |
258,293 |
|
||
| Restricted cash included in other current assets |
|
1,689 |
|
|
|
110 |
|
|
|
1,689 |
|
|
|
110 |
|
||
| Total cash, cash equivalents and restricted cash |
$ |
489,062 |
|
|
$ |
258,403 |
|
|
$ |
489,062 |
|
|
$ |
258,403 |
|
||
| PREPARED IN ACCORDANCE WITH GAAP | |||||||||||||||||
| PerkinElmer, Inc. and Subsidiaries | |||||||||||||||
| RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1) | |||||||||||||||
|
|
|||||||||||||||
| (In millions, except per share data and percentages) |
|
PKI | |||||||||||||
|
|
Three Months Ended |
||||||||||||||
|
|
October 3, 2021 |
October 4, 2020 |
|||||||||||||
|
|
|||||||||||||||
| Adjusted revenue: |
|
||||||||||||||
| Revenue |
|
$ |
1,166.7 |
|
$ |
964.0 |
|
||||||||
| Purchase accounting adjustments |
|
|
0.2 |
|
|
0.2 |
|
||||||||
| Adjusted revenue |
|
$ |
1,166.9 |
|
$ |
964.2 |
|
||||||||
|
|
|||||||||||||||
| Adjusted gross margin: |
|
||||||||||||||
| Gross margin |
|
$ |
631.8 |
|
54.2 |
% |
$ |
527.4 |
|
54.7 |
% |
||||
| Amortization of intangible assets |
|
|
32.1 |
|
2.8 |
% |
|
16.7 |
|
1.7 |
% |
||||
| Purchase accounting adjustments |
|
|
9.6 |
|
0.8 |
% |
|
0.5 |
|
0.0 |
% |
||||
| Adjusted gross margin |
|
$ |
673.5 |
|
57.7 |
% |
$ |
544.6 |
|
56.5 |
% |
||||
|
|
|||||||||||||||
| Adjusted SG&A: |
|
||||||||||||||
| SG&A |
|
$ |
339.0 |
|
29.1 |
% |
$ |
225.2 |
|
23.4 |
% |
||||
| Amortization of intangible assets |
|
|
(38.9 |
) |
-3.3 |
% |
|
(32.2 |
) |
-3.3 |
% |
||||
| Purchase accounting adjustments |
|
|
(1.2 |
) |
-0.1 |
% |
|
(2.6 |
) |
-0.3 |
% |
||||
| Acquisition and divestiture-related costs |
|
|
(49.1 |
) |
-4.2 |
% |
|
(0.2 |
) |
0.0 |
% |
||||
| Asset impairment |
|
|
(3.9 |
) |
-0.3 |
% |
|
– |
|
0.0 |
% |
||||
| Adjusted SG&A |
|
$ |
246.1 |
|
21.1 |
% |
$ |
190.2 |
|
19.7 |
% |
||||
|
|
|||||||||||||||
| R&D |
|
$ |
68.6 |
|
5.9 |
% |
$ |
50.1 |
|
5.2 |
% |
||||
|
|
|||||||||||||||
| Adjusted operating income: |
|
||||||||||||||
| Operating income |
|
$ |
222.0 |
|
19.0 |
% |
$ |
248.0 |
|
25.7 |
% |
||||
| Amortization of intangible assets |
|
|
71.0 |
|
6.1 |
% |
|
48.9 |
|
5.1 |
% |
||||
| Purchase accounting adjustments |
|
|
10.8 |
|
0.9 |
% |
|
3.1 |
|
0.3 |
% |
||||
| Acquisition and divestiture-related costs |
|
|
49.1 |
|
4.2 |
% |
|
0.2 |
|
0.0 |
% |
||||
| Asset impairment |
|
|
3.9 |
|
0.3 |
% |
|
– |
|
0.0 |
% |
||||
| Restructuring and other, net |
|
|
2.2 |
|
0.2 |
% |
|
4.1 |
|
0.4 |
% |
||||
| Adjusted operating income |
|
$ |
358.9 |
|
30.8 |
% |
$ |
304.3 |
|
31.6 |
% |
||||
|
|
|||||||||||||||
|
|
PKI | ||||||||||||||
|
|
Three Months Ended |
||||||||||||||
|
|
October 3, 2021 |
October 4, 2020 |
|||||||||||||
|
|
|||||||||||||||
| Adjusted EPS: |
|
||||||||||||||
| GAAP EPS |
|
$ |
1.11 |
|
$ |
1.57 |
|
||||||||
| Discontinued operations, net of income taxes |
|
|
(0.00 |
) |
|
(0.00 |
) |
||||||||
| GAAP EPS from continuing operations |
|
|
1.11 |
|
|
1.57 |
|
||||||||
| Amortization of intangible assets |
|
|
0.62 |
|
|
0.44 |
|
||||||||
| Purchase accounting adjustments |
|
|
0.09 |
|
|
0.03 |
|
||||||||
| Acquisition and divestiture-related costs |
|
|
0.63 |
|
|
0.00 |
|
||||||||
| Change in fair value of financial securities |
|
|
0.17 |
|
|
(0.00 |
) |
||||||||
| Asset impairment |
|
|
0.03 |
|
|
– |
|
||||||||
| Disposition of businesses and assets, net |
|
|
(0.02 |
) |
|
– |
|
||||||||
| Restructuring and other, net |
|
|
0.02 |
|
|
0.04 |
|
||||||||
| Tax on above items |
|
|
(0.34 |
) |
|
(0.12 |
) |
||||||||
| Significant tax items |
|
|
(0.01 |
) |
|
0.14 |
|
||||||||
| Adjusted EPS |
|
$ |
2.31 |
|
$ |
2.09 |
|
||||||||
|
|
|||||||||||||||
|
|
DAS | ||||||||||||||
|
|
Three Months Ended |
||||||||||||||
|
|
October 3, 2021 |
October 4, 2020 |
|||||||||||||
|
|
|||||||||||||||
| Adjusted revenue: |
|
||||||||||||||
| Revenue |
|
$ |
512.9 |
|
$ |
423.6 |
|
||||||||
| Purchase accounting adjustments |
|
|
– |
|
|
– |
|
||||||||
| Adjusted revenue |
|
$ |
512.9 |
|
$ |
423.6 |
|
||||||||
|
|
|||||||||||||||
| Adjusted operating income: |
|
||||||||||||||
| Operating income |
|
$ |
7.1 |
|
1.4 |
% |
$ |
42.7 |
|
10.1 |
% |
||||
| Amortization of intangible assets |
|
|
33.4 |
|
6.5 |
% |
|
17.6 |
|
4.2 |
% |
||||
| Purchase accounting adjustments |
|
|
5.7 |
|
1.1 |
% |
|
– |
|
0.0 |
% |
||||
| Acquisition and divestiture-related costs |
|
|
47.1 |
|
9.2 |
% |
|
0.2 |
|
0.1 |
% |
||||
| Restructuring and other, net |
|
|
1.6 |
|
0.3 |
% |
|
2.0 |
|
0.5 |
% |
||||
| Adjusted operating income |
|
$ |
94.9 |
|
18.5 |
% |
$ |
62.5 |
|
14.8 |
% |
||||
|
|
|||||||||||||||
|
|
Diagnostics | ||||||||||||||
|
|
Three Months Ended |
||||||||||||||
|
|
October 3, 2021 |
October 4, 2020 |
|||||||||||||
|
|
|||||||||||||||
| Adjusted revenue: |
|
||||||||||||||
| Revenue |
|
$ |
653.8 |
|
$ |
540.4 |
|
||||||||
| Purchase accounting adjustments |
|
|
0.2 |
|
|
0.2 |
|
||||||||
| Adjusted revenue |
|
$ |
654.0 |
|
$ |
540.6 |
|
||||||||
|
|
|||||||||||||||
| Adjusted operating income: |
|
||||||||||||||
| Operating income |
|
$ |
237.9 |
|
36.4 |
% |
$ |
223.8 |
|
41.4 |
% |
||||
| Amortization of intangible assets |
|
|
37.5 |
|
5.7 |
% |
|
31.3 |
|
5.8 |
% |
||||
| Purchase accounting adjustments |
|
|
5.1 |
|
0.8 |
% |
|
3.1 |
|
0.6 |
% |
||||
| Asset impairment |
|
|
3.9 |
|
0.6 |
% |
|
– |
|
0.0 |
% |
||||
| Acquisition and divestiture-related costs |
|
|
2.0 |
|
0.3 |
% |
|
0.0 |
|
0.0 |
% |
||||
| Restructuring and other, net |
|
|
0.6 |
|
0.1 |
% |
|
2.1 |
|
0.4 |
% |
||||
| Adjusted operating income |
|
$ |
287.0 |
|
43.9 |
% |
$ |
260.3 |
|
48.2 |
% |
||||
|
|
|||||||||||||||
| (1) amounts may not sum due to rounding |
|
||||||||||||||
| PerkinElmer, Inc. and Subsidiaries | |||||||||||||||
| RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1) | |||||||||||||||
| (In millions, except per share data and percentages) | PKI | ||||||||||||||
|
Nine Months Ended |
|||||||||||||||
|
October 3, 2021 |
October 4, 2020 |
||||||||||||||
| Adjusted revenue: | |||||||||||||||
| Revenue |
$ |
3,702.8 |
|
$ |
2,428.1 |
|
|||||||||
| Purchase accounting adjustments |
|
2.4 |
|
|
0.6 |
|
|||||||||
| Adjusted revenue |
$ |
3,705.3 |
|
$ |
2,428.7 |
|
|||||||||
| Adjusted gross margin: | |||||||||||||||
| Gross margin |
$ |
2,102.2 |
|
56.8 |
% |
$ |
1,282.8 |
|
52.8 |
% |
|||||
| Amortization of intangible assets |
|
75.1 |
|
2.0 |
% |
|
48.8 |
|
2.0 |
% |
|||||
| Purchase accounting adjustments |
|
17.2 |
|
0.5 |
% |
|
2.3 |
|
0.1 |
% |
|||||
| Adjusted gross margin |
$ |
2,194.4 |
|
59.2 |
% |
$ |
1,333.9 |
|
54.9 |
% |
|||||
| Adjusted SG&A: | |||||||||||||||
| SG&A |
$ |
872.3 |
|
23.6 |
% |
$ |
654.8 |
|
27.0 |
% |
|||||
| Amortization of intangible assets |
|
(109.6 |
) |
-3.0 |
% |
|
(94.1 |
) |
-3.9 |
% |
|||||
| Purchase accounting adjustments |
|
(1.6 |
) |
0.0 |
% |
|
8.8 |
|
0.4 |
% |
|||||
| Acquisition and divestiture-related costs |
|
(69.4 |
) |
-1.9 |
% |
|
(7.4 |
) |
-0.3 |
% |
|||||
| Asset impairment |
|
(3.9 |
) |
-0.1 |
% |
|
– |
|
0.0 |
% |
|||||
| Significant litigation matters and settlements |
|
– |
|
0.0 |
% |
|
(3.6 |
) |
-0.2 |
% |
|||||
| Significant environmental matters |
|
– |
|
0.0 |
% |
|
(5.2 |
) |
-0.2 |
% |
|||||
| Adjusted SG&A |
$ |
687.8 |
|
18.6 |
% |
$ |
553.3 |
|
22.8 |
% |
|||||
| R&D |
$ |
194.6 |
|
5.3 |
% |
$ |
148.6 |
|
6.1 |
% |
|||||
| Adjusted operating income: | |||||||||||||||
| Operating income |
$ |
1,022.2 |
|
27.6 |
% |
$ |
468.3 |
|
19.3 |
% |
|||||
| Amortization of intangible assets |
|
184.7 |
|
5.0 |
% |
|
142.9 |
|
5.9 |
% |
|||||
| Purchase accounting adjustments |
|
18.8 |
|
0.5 |
% |
|
(6.5 |
) |
-0.3 |
% |
|||||
| Acquisition and divestiture-related costs |
|
69.4 |
|
1.9 |
% |
|
7.4 |
|
0.3 |
% |
|||||
| Asset impairment |
|
3.9 |
|
0.1 |
% |
|
– |
|
0.0 |
% |
|||||
| Significant litigation matters and settlements |
|
– |
|
0.0 |
% |
|
3.6 |
|
0.2 |
% |
|||||
| Significant environmental matters |
|
– |
|
0.0 |
% |
|
5.2 |
|
0.2 |
% |
|||||
| Restructuring and other, net |
|
13.0 |
|
0.4 |
% |
|
11.1 |
|
0.5 |
% |
|||||
| Adjusted operating income |
$ |
1,312.0 |
|
35.4 |
% |
$ |
632.1 |
|
26.0 |
% |
|||||
| PKI | |||||||||||||||
|
Nine Months Ended |
|||||||||||||||
|
October 3, 2021 |
October 4, 2020 |
||||||||||||||
| Adjusted EPS: | |||||||||||||||
| GAAP EPS |
$ |
6.65 |
|
$ |
3.10 |
|
|||||||||
| Discontinued operations |
|
(0.00 |
) |
|
(0.00 |
) |
|||||||||
| GAAP EPS from continuing operations |
|
6.65 |
|
|
3.11 |
|
|||||||||
| Amortization of intangible assets |
|
1.63 |
|
|
1.28 |
|
|||||||||
| Purchase accounting adjustments |
|
0.17 |
|
|
(0.06 |
) |
|||||||||
| Significant litigation matters and settlements |
|
– |
|
|
0.03 |
|
|||||||||
| Significant environmental matters |
|
– |
|
|
0.05 |
|
|||||||||
| Acquisition and divestiture-related costs |
|
0.77 |
|
|
0.07 |
|
|||||||||
| Change in fair value of financial securities |
|
(0.08 |
) |
|
(0.00 |
) |
|||||||||
| Asset impairment |
|
0.03 |
|
|
– |
|
|||||||||
| Disposition of businesses and assets, net |
|
(0.02 |
) |
|
– |
|
|||||||||
| Restructuring and other, net |
|
0.11 |
|
|
0.10 |
|
|||||||||
| Tax on above items |
|
(0.55 |
) |
|
(0.37 |
) |
|||||||||
| Significant tax items |
|
0.12 |
|
|
0.14 |
|
|||||||||
| Adjusted EPS |
$ |
8.84 |
|
$ |
4.33 |
|
|||||||||
| DAS | |||||||||||||||
|
Nine Months Ended |
|||||||||||||||
|
October 3, 2021 |
October 4, 2020 |
||||||||||||||
| Adjusted revenue: | |||||||||||||||
| Revenue |
$ |
1,480.3 |
|
$ |
1,213.0 |
|
|||||||||
| Purchase accounting adjustments |
|
1.8 |
|
|
– |
|
|||||||||
| Adjusted revenue |
$ |
1,482.2 |
|
$ |
1,213.0 |
|
|||||||||
| Adjusted operating income: | |||||||||||||||
| Operating income |
$ |
114.2 |
|
7.7 |
% |
$ |
110.6 |
|
9.1 |
% |
|||||
| Amortization of intangible assets |
|
76.9 |
|
5.2 |
% |
|
58.8 |
|
4.8 |
% |
|||||
| Purchase accounting adjustments |
|
9.3 |
|
0.6 |
% |
|
(11.3 |
) |
-0.9 |
% |
|||||
| Acquisition and divestiture-related costs |
|
61.6 |
|
4.2 |
% |
|
7.0 |
|
0.6 |
% |
|||||
| Significant litigation matters and settlements |
|
– |
|
0.0 |
% |
|
2.4 |
|
0.2 |
% |
|||||
| Restructuring and other, net |
|
9.4 |
|
0.6 |
% |
|
6.7 |
|
0.6 |
% |
|||||
| Adjusted operating income |
$ |
271.4 |
|
18.3 |
% |
$ |
174.3 |
|
14.4 |
% |
|||||
| Diagnostics | |||||||||||||||
|
Nine Months Ended |
|||||||||||||||
|
October 3, 2021 |
October 4, 2020 |
||||||||||||||
| Adjusted revenue: | |||||||||||||||
| Revenue |
$ |
2,222.5 |
|
$ |
1,215.1 |
|
|||||||||
| Purchase accounting adjustments |
|
0.6 |
|
|
0.6 |
|
|||||||||
| Adjusted revenue |
$ |
2,223.1 |
|
$ |
1,215.7 |
|
|||||||||
| Adjusted operating income: | |||||||||||||||
| Operating income |
$ |
965.7 |
|
43.4 |
% |
$ |
413.7 |
|
34.0 |
% |
|||||
| Amortization of intangible assets |
|
107.7 |
|
4.8 |
% |
|
84.0 |
|
6.9 |
% |
|||||
| Purchase accounting adjustments |
|
9.5 |
|
0.4 |
% |
|
4.9 |
|
0.4 |
% |
|||||
| Asset impairment |
|
3.9 |
|
0.2 |
% |
|
– |
|
0.0 |
% |
|||||
| Acquisition and divestiture-related costs |
|
7.8 |
|
0.4 |
% |
|
0.3 |
|
0.0 |
% |
|||||
| Significant litigation matters and settlements |
|
– |
|
0.0 |
% |
|
1.2 |
|
0.1 |
% |
|||||
| Restructuring and other, net |
|
3.7 |
|
0.2 |
% |
|
4.3 |
|
0.4 |
% |
|||||
| Adjusted operating income |
$ |
1,098.2 |
|
49.4 |
% |
$ |
508.5 |
|
41.8 |
% |
|||||
| (1) amounts may not sum due to rounding | |||||||||||||||
Contacts
Investor Relations:
PerkinElmer, Inc.
Steve Willoughby (781) 663-5677
steve.willoughby@perkinelmer.com
Media Contact:
PerkinElmer, Inc.
Fara Goldberg (781) 663-5699
fara.goldberg@perkinelmer.com